top of page
Blue-Orange Linac 3_edited.jpg

The International
Radiosurgery Oncology Consortium for Kidney
(IROCK) Registry

The International Radiosurgery Oncology Consortium for Kidney (IROCK) collaborates on research into stereotactic ablative radiotherapy (SABR) for primary renal cell carcinoma (RCC). The primary purpose of the IROCK Registry is to evaluate the time between SABR treatment and recurrence (when cancer returns after treatment) that occurs in the area of the initial tumour, in patients with RCC. The secondary objective of the study will assess efficacy and survival outcomes.

More information

Analyzing Scans
Working on the laptop
Elekta Unity - Radiographer Planning Consult .JPG

More about SABR in RCC

The IROCK Registry

IROCK's
work to date

No events at the moment

CONTACT US

The IROCK Registry database is housed and maintained by the Peter MacCallum Cancer Centre in Melbourne, Australia. Feel free to get in touch with the Registry Coordinator with questions or comments regarding the work of the registry.

bottom of page